Journal ArticleOPEN ACCESS

Hypofractionated Prostate Radiation Therapy: Adoption and Dosimetric Adherence Through Clinical Pathways in an Integrated Oncology Network

  • Schad M
  • Patel A
  • Ling D
  • et al.
JCO Oncology Practice (2021) 17(4) e537-e547
DOI: 10.1200/op.20.00508
4Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

PURPOSE:Updates to consensus guidelines in October 2018 recommending moderately hypofractionated external beam radiotherapy (mHF-EBRT) in prostate cancer lagged several years after publication of e...

Cite

CITATION STYLE

APA

Schad, M. D., Patel, A. K., Ling, D. C., Smith, R. P., & Beriwal, S. (2021). Hypofractionated Prostate Radiation Therapy: Adoption and Dosimetric Adherence Through Clinical Pathways in an Integrated Oncology Network. JCO Oncology Practice, 17(4), e537–e547. https://doi.org/10.1200/op.20.00508

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free